Florida Cancer Affiliates Acquires Radiation Oncology Facility in Panama City

August 04, 2015

Acquisition enhances comprehensive cancer care in North Florida

Panama City, Fla. (August 4, 2015) – Florida Cancer Affiliates (FCA), a practice in The US Oncology Network, acquired a radiation oncology facility in Panama City. The acquisition allows the medical oncologists of FCA to offer a full range of both medical oncology and radiation oncology treatment to patients in North Florida.

“We thrive on offering optimal cancer care to our patients,” said Shawn Gallagher, practice administrator, Florida Cancer Affiliates. “The addition of radiation oncology in North Florida brings patients the opportunity to receive more comprehensive, integrated cancer care in the convenience and comfort of a community setting.”

The 23 physicians with Florida Cancer Affiliates use the latest technologies and drug therapies to offer patients advanced treatment options in 14 locations throughout Florida. This comprehensive care includes outpatient treatment and diagnostic facilities providing chemotherapy; hematology services; radiation therapy including stereotactic and PET/CT imaging; clinical research; pharmacy and laboratory; financial counseling; and patient support services.

Florida Cancer Affiliates offers the following types of radiation therapies and procedures:

  • External radiation
    • Radiation treatment for skin cancer
    • Electron beam therapy
    • Three dimensional conformal therapy
    • Intensity modulated radiation therapy (IMRT)
    • Stereotactic radiation therapy (SRS-SBRT)
  • Interstitial internal radiation, utilizing
    • Low dose rate permanent implants
    • High dose rate temporary implants

“We are the only cancer center in Panama City to integrate chemotherapy and radiation treatment services for cancer patients,” said Syed Tariq Mahmood, M.D., oncologist and president of the FCA North Florida Division. “It took years of hard work to get here, but we think our patients will see the results of this work in improved quality of treatment and safety of care.”

The new FCA radiation facility is located at 2100 State Avenue, Panama City, Florida 32405. For more information or to make an appointment, please call 850-763-0036.

About Florida Cancer Affiliates

Florida Cancer Affiliates (FCA) is a community-based radiation oncology, medical oncology, and hematology practice with convenient locations throughout Florida, from Naples and Ft. Myers to Trinity, Hudson, Brooksville, The Villages, Ocala and Panama City. The integrated clinical team of FCA employs the latest technologies and drug therapies to ensure patients receive advanced care close to home. The comprehensive treatment centers include outpatient treatment and diagnostic facilities providing chemotherapy, hematology services, radiation therapy including stereotactic and PET/CT imaging, clinical research, pharmacy and laboratory, as well as financial counseling and patient support services.

The practice is committed to providing patients with advanced care. They offer therapies proven to be effective, along with advanced diagnostic and treatment technologies. They also provide access to new investigational drugs through clinical trials. By participating in clinical trials that test new drugs or various combinations of treatments, patients have the opportunity to receive new therapies not yet available outside these clinical trials. To learn more about Florida Cancer Affiliates, go to www.floridacancer.com.

Florida Cancer Affiliates is united in healing with The US Oncology Network, one of the nation’s largest networks of integrated community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. As an affiliate of The US Oncology Network, FCA is united with 1,000 physicians nationwide. Florida Cancer Affiliates participates in clinical trials through US Oncology Research, which has played a role in more than 50 FDA-approved cancer therapies, nearly one-third of all cancer therapies approved by the FDA to date. For more information, visit www.usoncology.com.

Public Relations Contact